Il Giornale di AMD
Idelson Gnocchi · Italy · Est. 2017
Aims & Scope✦ Inferred from recent articles
Il Giornale di AMD focuses on diabetes mellitus, particularly type 1 and type 2, and its management. The journal covers advancements in diabetes technology, including continuous glucose monitoring, automated insulin delivery systems, and digital health solutions. It also addresses complications of diabetes such as diabetic foot and neuropathy, and explores the role of lifestyle factors like breakfast consumption and exercise in diabetes care. The scope includes research on pharmacological treatments, patient care profiles, and the evolving landscape of digital health in diabetes management.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Il Giornale di AMD
Is Il Giornale di AMD a predatory journal?
PubScope has no integrity flags on record for Il Giornale di AMD: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Il Giornale di AMD?
Il Giornale di AMD is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its open 2-year mean citedness is 0.04.
Is Il Giornale di AMD indexed in Scopus and Web of Science?
Il Giornale di AMD is indexed in DOAJ.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref